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We asked whether retinoic acid (RA), an established transcriptional regulator in regenerating and developing tissues, acts directly on
distinct cell classes in the mature or embryonic forebrain. We identified a subset of slowly dividing precursors in the adult subventricular
zone (SVZ) that is transcriptionally activated by RA. Most of these cells express glial fibrillary acidic protein, a smaller subset expresses
the epidermal growth factor receptor, a few are terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling
positive, and they can be mitotically labeled by sustained rather than acute bromodeoxyuridine exposure. RA activation in similar cells in
SVZ-derived neurospheres depends on retinoid synthesis from the premetabolite retinol. The apparent influence of RA on precursors in
vitro is consistent with key properties of RA activation in the SVZ; in neurospheres, altered retinoid signaling elicits neither cell death nor
an acute increase in cell proliferation. There is apparent continuity of RA signaling in the forebrain throughout life. RA-activated,
proliferative precursors with radial glial characteristics are found in the dorsal lateral ganglionic eminence and ventrolateral pallium–
embryonic rudiments of the SVZ. Thus, endogenous RA signaling distinguishes subsets of neural precursors with glial characteristics in
a consistent region of the adult and developing forebrain.
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Introduction
Retinoic acid (RA) signaling is required for olfactory pathway
development and continues in the olfactory region as well as
other forebrain regions throughout life (LaMantia et al., 1993,
2000; Anchan et al., 1997; Whitesides et al., 1998; Haskell et al.,
2002). Nevertheless, the anatomical sites, cellular targets, and
consequences of RA signaling in the forebrain remain obscure.
These issues cannot be fully resolved by localizing retinoid recep-
tors and cofactors or manipulating retinoid levels in vivo or in
vitro (Rubin and LaMantia, 1999; Mic et al., 2004). Such approaches,
while informative, cannot identify cells that respond to endogenous
RA via signaling pathways, the activity of which is not significantly
altered by acutely increased retinoid concentrations (for review, see
Bastien and Rochette-Egly, 2004). To circumvent these difficulties,
we evaluated endogenous RA signaling in adult and developing fore-
brain precursors or their neural and glial progeny using mice carry-
ing an RA-responsive reporter transgene (Balkan et al., 1992; Colbert
et al., 1993; Haskell et al., 2002).
Endogenous RA signaling in the forebrain may function as it
does in the skin, lens, liver, lung, amphibian limbs, and deer
antlers. At each site, RA influences regeneration or development
by modulating gene expression in RA-responsive cells (Lutzow-
Holm et al., 1992; Tsonis et al., 2000, 2002; Imai et al., 2001; Allen
et al., 2002; Hind and Maden, 2004). RA may regulate compara-
ble processes in olfactory bulb (OB) granule cells as well as adult
or embryonic precursors that generate these interneurons
throughout life (Doetsch et al., 1999a,b; Haskell et al., 2002; Sten-
man et al., 2003). Ventricles and associated tissues are significant
RA sources (Herbert et al., 1986; Yamamoto et al., 1996; Smith et
al., 2001), and retinoid synthetic enzymes, receptors, and cofac-
tors are present in olfactory structures in the mature and devel-
oping forebrain (Krezel et al., 1999; Smith et al., 2001; Haskell et
al., 2002; Yee and Rawson, 2005). Accordingly, we determined
whether endogenous RA signaling distinguishes newly generated
olfactory granule cells as well as molecularly defined precursors
in the adult subventricular zone (SVZ) or its embryonic
rudiments.
RA may influence survival, proliferation, or differentiation in
distinct cell classes at specific forebrain sites from early develop-
ment through adulthood. Altered RA signaling can reduce telen-
cephalic size, influence neurogenic markers, disrupt cell migra-
tion, and alter complex behaviors, including learning and
memory (Chiang et al., 1998; Denisenko-Nehrbass et al., 2000;
Giardino et al., 2000; Smith et al., 2001; Wang et al., 2005). De-
spite many suggestive observations, there is little evidence that
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RA modulates these processes via specific actions on identified
cell classes. Accordingly, we assessed the influence of RA on fore-
brain precursors in vivo and in vitro throughout life. Our results
suggest that endogenous RA, via distinct metabolic and tran-
scriptional pathways, regulates cell proliferation in a subset of
slowly dividing astrocytes in the adult SVZ, as well as a subset of
proliferative radial glia in a comparable region of the developing
forebrain.
Materials and Methods
Animals. The Institutional Animal Care and Use Committee at the Uni-
versity of North Carolina at Chapel Hill reviewed and approved all ani-
mal experiments. Wild-type Institute of Cancer Research (ICR) mice as
well as two independent lines of RA-sensitive transgenic (TG) mice on an
ICR background (TG1 and TG2) were maintained by the University of
North Carolina at Chapel Hill Department of Laboratory Animal Medi-
cine. Timed pregnancies were generated by pairing ICR females with a
homozygous transgenic male late in the day and defining embryonic day
0.5 (E0.5) the following morning, based on a vaginal plug. All animals
used for immunocytochemical, in situ, or histochemical analyses were
deeply anesthetized with urethane (2 mg/kg) before perfusion. For neu-
rosphere preparation, animals were killed by rapid cervical dislocation
before harvesting brain tissues.
Bromodeoxyuridine administration in vivo. To label newly generated
neurons in adult mice [postnatal day 60 (P60)], bromodeoxyuridine
(BrdU) (dissolved in 0.07N NaOH in 0.9% NaCl; Sigma, St. Louis, MO)
was injected intraperitoneally at 75 mg/kg for 4 d, and animals were
perfused 3 weeks later (n  3). To label earlier born granule cells, BrdU
was injected once daily from P0 –P5, and animals were perfused at P60
(n  3). To label rapidly dividing SVZ cells, P60 animals received a single
BrdU injection and were perfused 2.5 h later. To label resident precur-
sors, P60 animals were given BrdU (10 mg/ml) in their drinking water for
1 week and subsequently given regular drinking water for 1 month before
they were killed (n  3 TG1 and 3 TG2 mice).
Immunostaining and histochemistry. Brains from 3- to 6-month-old
male TG mice, perfused with 2.5% paraformaldehyde in 0.1 M sodium
phosphate buffer, pH 7.4, were cryoprotected in graded sucrose, embed-
ded in agar-sucrose, and frozen in cryoembedding compound (OCT).
Twenty micrometer cryosections were incubated with 0.2% BSA, 20%
NGS, and 0.6% Triton X-100 in 0.1 M PBS for 2 h before applying 1°
antibody in a similar solution with 0.3% Triton X-100 overnight. Alexa-
series fluorescent 2° antibodies were used (1:5000; Molecular Probes,
Eugene, OR), and preparations were mounted in polyvinyl alcohol
(Mowiol; Calbiochem, La Jolla, CA) with an anti-photobleaching com-
pound (paraphenylene diamine). For BrdU detection, sections were first
immunostained for other markers, incubated for 30 min in 2N HCl at
37°C followed by 0.1 M NaBH4, and stained with an anti-BrdU antibody.
Terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick
end labeling (TUNEL) labeling (Roche Products, Hertfordshire, UK) was
performed before immunostaining for -galactosidase. Controls omit-
ting either 1 or 2° antibodies were performed for all markers (supplemen-
tal Table 1, available at www.jneurosci.org as supplemental material).
Epifluorescent images were acquired on a Leica (Nussloch, Germany)
Digital Microscopy Research microscope using Openlab software and
were adjusted for contrast or size in Adobe Photoshop (Adobe Systems,
San Jose, CA). For histochemical detection of -galactosidase, E14.5
brains were immersion fixed (4 h at room temperature in 2.5% parafor-
maldehyde in 0.1 M phosphate buffer), vibratome-sectioned at 100 m,
and stained histochemically as described previously (Colbert et al., 1993).
These sections were mounted in phosphate buffer and videoimaged on a
Leica-Wild MZ420 photomacroscope.
In situ hybridization. In situ hybridization on adult and E13.5 brains
fixed by perfusion (adult) or immersion (E13.5) with 4% paraformalde-
hyde in 0.1 M phosphate buffer was performed on 15 m cryostat sections
through the SVZ or ventral pallium/dorsal lateral ganglionic eminence
(dLGE). Digoxygenin-labeled antisense probes were synthesized for reti-
noic acid receptor  (RAR), RAR (Rubin and LaMantia, 1999), or
retinaldehyde dehydrogenase 3 (RALDH3) (gift from P. McCafferey, E.
K. Shriver Research Institute, Waltham, MA). Hybridized sections were
dehydrated, coverslipped, and videoimaged on a Leica DM IRB
microscope.
Quantification. To estimate the percentage of RA-activated granule
cells at P60 that were generated between P0 and P5 (the peak of initial
granule cell genesis) (Hinds, 1968), we estimated the percentage of trans-
gene/BrdU double-labeled cells compared with the total number of
transgene-labeled cells in the granule cell layer of the P60 olfactory bulb.
We counted cells in three systematically positioned fields at an initial mag-
nification of 400 from the dorsal, middle, and ventral regions of the gran-
ule layer in four evenly spaced coronal sections from three P60 mice.
Summed totals of all fields from individual animals were averaged to gener-
ate a percentage, with SEM representing variation among animals.
To analyze coexpression of multiple markers [i.e., transgene, GFAP,
epidermal growth factor (EGF) receptor (EGFR), and BrdU], every
transgene-labeled cell in three evenly spaced 20 m coronal sections
through the anterior SVZ of three animals double-labeled for the trans-
gene and each of the other markers was serially optically sectioned on a
Zeiss (Thornwood, NY) LSM510 multiphoton confocal microscope
(University of North Carolina Neuroscience Center Confocal Micros-
copy Core). The anteroposterior extent of the SVZ was defined by the
rostral-most point of the genu of the corpus callosum (CC) and the initial
appearance of the anterior commissure, respectively. Only sections that
contained 10 or more transgene-labeled cells were analyzed, and our
criterion for double labeling was colocalization in three or more consec-
utive 0.5 m optical sections. The sample fields included all transgene-
labeled cells within 50 m of the lateral aspect of the lateral ventricle and
400 m of the ventricular surface of the dorsolateral arm of the SVZ. A
total of 141 transgene-labeled cells were examined for GFAP expression,
152 were examined for EGFR, and 274 were examined for BrdU incor-
poration after long-term exposure. In addition, 133 long-term BrdU-
labeled cells were examined for GFAP expression alone. We also counted
the number of acutely BrdU-labeled SVZ cells that coexpress GFAP in
three randomly selected 40 maximum projection images from three
evenly spaced sections from three mice. A total of 385 acutely labeled
BrdU cells were analyzed, and two independent observers reported sim-
ilar percentages of double-labeled cells.
Embryonic and adult neurosphere cultures. For each adult neurosphere
experiment, SVZ cells from a single animal were dissociated after 40 min
of incubation (37°C, 5% CO2) in trypsin, hyaluronidase, and DNase in
Neurobasal-A (Invitrogen, San Diego, CA), 50 mM HEPES, 1 standard
or retinol-free B-27 with N2 supplement (Invitrogen), 1 pen-strep, and
20 ng/ml recombinant human EGF/recombinant human basic FGF
(Promega, Madison, WI). Cells were strained through a 40 m filter,
spun, resuspended in 1 ml of medium, and plated in 24-well dishes at
1000 cells/well. They were fed EGF and FGF every 3 d, one-half of the
media was exchanged on day 7, and they were analyzed for gene, trans-
gene, or protein expression on day 9 or 10. To induce differentiation, neu-
rospheres were placed on poly-lysine/laminin (5 g/ml; Roche)-coated
chamber slides (Nunc, Naperville, IL) in media without EGF or FGF and
supplemented with 1% fetal bovine serum. For whole-mount staining, un-
differentiated primary neurospheres were placed onto coated chamber slides
in growth media and were fixed and stained immediately after they had
attached to the poly-lysine/laminin substrate (usually 3–4 h).
For embryonic neurospheres, ventricular/SVZ cells from the rostral
forebrain of three E14.5 TG or ICR fetuses per experiment were dissoci-
ated after 15 min (37°C; 5% CO2) in 1 trypsin and 10 g/ml DNase in
supplemented media consisting of DMEM/F-12 (Invitrogen) with 0.6%
D-glucose, 1 pen-strep, 2.5 g/ml insulin, 10 g/ml transferrin, 2 nM
progesterone, 6 M putrescine, 3 nM selenium chloride, 2 mM glutamine
(Sigma), and 1 B-27. Cells were strained, spun, resuspended as de-
scribed above, and plated in six-well dishes at 5000/well. Cultures were
fed on day 3 with 20 ng/ml EGF and FGF. Some neurospheres were
evaluated for transgene expression on day 5 or 6, and others were differ-
entiated and analyzed for neuronal or glial markers.
Transgene detection in living neurospheres. 5-Chloromethylfluorescein
di--D-galactopyranoside (CMFDG) (100 m; Molecular Probes) was
added to pooled neurospheres using brief hypotonic shock (90 s). After
this CMFDG exposure, cells were flooded with fresh growth media and
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incubated for 1 h before analyzing. The number
of spheres containing at least one fluorescent
cell was determined by viewing neurospheres
live on an inverted Leica DM IRB microscope.
All-trans RA and diethylaminobenzaldehyde
(DEAB) (Sigma) were maintained as 10 2 M
stock in DMSO and diluted as indicated.
BrdU labeling in vitro. Neurospheres were
grown in control media as described above for 1
week. On day 8, neurospheres derived from the
same animal were exposed to either 10 6 or
10 7 M all-trans RA, 10 nM DEAB, or 0.1%
DMSO for 24 h. Individual neurospheres were
then placed, one per well, in coated chamber
slides with fresh growth media containing 5
g/ml BrdU. Cultures were fixed 24 h later and
stained for BrdU as described above. In the pla-
nar cultures that grew under these conditions,
six fields (at an initial magnification of 400)
were counted to obtain a mean ratio of BrdU-
labeled cells. Four spheres were analyzed per
condition, and the proportion of BrdU-labeled
cells from three experiments was averaged (i.e.,
n  12 spheres for each condition). Each con-
dition was compared with control using Mann–
Whitney nonparametric statistical analysis.
Reverse transcription-PCR. Two independent
RNA samples were extracted in Trizol (Invitro-
gen) from either grossly microdissected SVZ
(two TG2 males) or 15–20 pooled primary TG2
neurospheres. Reverse transcription (RT) was
performed using Promega reagents and ran-
dom hexamers after DNase treatment (40 min).
cDNA was diluted 1:3 and used as template for
PCR (36 cycles). All primers (supplemental Ta-
ble 2, available at www.jneurosci.org as supple-
mental material) were designed to span intron/
exon boundaries and were verified by amplicon
sequencing as well as no-RT enzyme controls.
Live/dead assay on SVZ cells. Dissociated SVZ
cells were cultured under neurosphere-
generating conditions and plated in tissue
culture-treated chamber slides (Nunc) at five-
fold higher density. Each day, for 7 d after plat-
ing, Ethidium-D and calcein (Cell Viability kit;
Molecular Probes) were added in PBS at a final
concentration of 5 and 1 M, respectively, and
cultures were incubated at 37°C for 30 min. For
each experiment, the proportion of dead cells in
nine fields (initial magnification, 400) from
two wells was averaged for each condition and
time point.
Results
Transgene-labeled cells in the adult
forebrain are not newly
generated neurons
Transgene-labeled, presumably RA-activated, cells are promi-
nent in the adult olfactory bulb and SVZ (Haskell et al., 2002).
Thus, we first asked whether the DR5-RA response element
(RARE) transgene distinguishes newly generated neurons.
Transgene-labeled cells in the SVZ and OB granule cell layer do
not express polysialylated neural cell adhesion molecule (PSA-
NCAM) or doublecortin (Fig. 1A,B) (data not shown). There are
occasional transgene-labeled cells in the rostral migratory stream
(RMS); however, unlike migratory neuroblasts destined for the
OB, they do not express PSA-NCAM (Fig. 1B). To directly assess
whether transgene-labeled cells in the OB are newly generated, we
injected BrdU once daily for 4 d in adult TG mice and examined
incorporation 3 weeks later. Despite many BrdU-labeled cells in
the OB, we did not detect any transgene/BrdU double-labeled
cells in multiple serial sections from three transgenic mice (Fig.
1C). Thus, although transgene-labeled cells are present in the
adult SVZ and OB, the two populations are not directly related.
Our previous observations demonstrate that RA-activated
cells in the mature bulb are GABAergic granule cells (Haskell et
al., 2002). Thus, we next asked whether they might represent a
relatively stable subset generated during early phases of post-
natal granule cell genesis (Hinds, 1968). At P60, after once-
Figure 1. RA-activated cells in the SVZ and bulb are not newly generated neurons. A, Transgene-labeled cells (red; all panels)
are distinct from PSA-NCAM-labeled cells (green) in the adult SVZ. Inset, Segregation of transgene and PSA-NCAM-labeled cells at
higher magnification. B, Transgene-labeled cells in the RMS (in the sagittal section) are occasionally interspersed with PSA-NCAM-
labeled cells (arrows), but they do not appear to be PSA-NCAM labeled. In the OB granule cell layer, transgene and PSA-NCAM-
labeled cells are also distinct. Inset, Segregation of individual transgene and PSA-NCAM-labeled cells in the OB. C, Trans-
gene-labeled cells in the adult OB are not BrdU positive (green) 3 weeks after 4 d of once-daily BrdU injections. Inset, Higher
magnification of the boxed area in C shows segregation of transgene and BrdU labeling. D, BrdU-labeled, transgene-labeled cells
(yellow) can be identified in the adult bulb after once-daily BrdU injections between P0 and P5 (arrows). E–G, Examples of
transgene/BrdU double-labeled cells in the adult OB after early postnatal (P0 –P5) BrdU exposure (arrows). H, Transgene-labeled
cells are distinct from TUNEL-labeled cells (green) in the bulb at P10. Scale bars: A, B, 100 m; C, D, H, 25 m; E–G, 40 m.
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daily BrdU injections between P0 and P5, 17.4% of the trans-
gene-labeled cells are also BrdU labeled (SEM, 1.25) (Fig. 1 D–
G). Despite significant apoptosis in the bulb, particularly in
the granule cell layer, during the first postnatal month (Fiske
and Brunjes, 2001; Saito et al., 2004), transgene-labeled cells
are distinct from TUNEL-positive cells at P10 (Fig. 1 H). Ap-
parently, RA activation in the OB is associated with a relatively
stable population of granule cells generated during early post-
natal development.
RA-activated SVZ cells express general markers of
neural precursors
To determine whether RA-activated cells in the SVZ are related to
any class of adult neural precursors, we first examined coexpres-
sion of Nestin, Sox1, and Sox2, all of which are generally associ-
ated with neural precursor cells (Pevny and Rao, 2003). Nestin is
colocalized in all transgene-labeled cells examined (Fig. 2A–C),
including many large, fusiform cells with single processes ori-
ented away from the ventricle (Fig. 2D–F). RA-activated cells
comprise a subset of Sox1- and Sox2-positive cells in the SVZ
(Fig. 2G,H). These cells also express p27Kip1 (Fig. 2 I), an RA-
regulated modulator of cell proliferation associated with neural
precursors as well as astrocytes in a variety of mitotic states (Dirks
et al., 1997; Legrier et al., 2001; Nakatsuji and Miller, 2001;
Doetsch et al., 2002). The coincident expression of three charac-
teristic markers (Nestin, Sox1, and Sox2) as well as an established
RA-sensitive regulator of cell proliferation (p27Kip1) suggests
that RA-activated cells in the SVZ are mitotically active precur-
sors rather than recently postmitotic or differentiated neurons.
RA-activated cells in the SVZ are not
transit-amplifying precursors
To assess whether RA-activated precursors in the SVZ are rapidly
dividing transit-amplifying cells (Morshead et al., 1994), we gave
a single injection of BrdU to adult TG mice and assessed labeling
2.5 h later. The transgene-labeled population was not coincident
with the acutely BrdU-labeled, presumed transit-amplifying SVZ
population. Transgene-labeled cells are most prominent in the
dorsolateral aspect of the SVZ and are apparently larger and less
frequent than acutely labeled BrdU-positive cells (Fig. 3A,B).
SVZ neurogenesis is accompanied by cell death among most
transit-amplifying cells (Thomaidou et al., 1997; Morshead et al.,
1998). Thus, we asked whether transgene-labeled SVZ cells are
Figure 2. RA-activated SVZ cells express neural precursor and mitotic markers. A, B, Color-
separated images of five adjacent transgene-expressing cells (A, arrows) situated within a
network of nestin-labeled processes (B, arrows) in a single optical section (0.5 m) through the
SVZ, in a region adjacent to the ventricle (V). C, Merged image of A and B confirms coincidence
of transgene and nestin labeling. D, E, Color-separated images of a fusiform transgene-labeled
cell (D) with a single process oriented away from the ventricle seen within a network of nestin-
labeled processes (E). F, Merged image of the single optical section in D and E shows that this
cell, which has the morphology suggested for neural stem cells in the SVZ (Garcia et al., 2004) is
double labeled for the transgene and nestin. G, A subset of Sox1-labeled SVZ cells (green) also
expresses the transgene (red). H, A subset of Sox2-labeled cells (green) also expresses the
transgene (red). I, Transgene-labeled cells (red) express p27Kip1 (green), which is more broadly
expressed in the adult SVZ. Inset, An example of a single large transgene-labeled cell that also
expresses p27Kip1. Scale bars: A–C, 10 m; G, H, 10 m; width of images in D–F, 10 m.
Figure 3. RA-activated cells in the SVZ are not transit-amplifying precursors or dying cells. A,
Transgene-labeled cells (red) in the SVZ are not BrdU positive (green) 2.5 h after a single injec-
tion of BrdU. B, Higher-magnification image showing segregation of acute BrdU-labeled SVZ
cells, which are more frequent, and transgene-labeled cells, which are slightly larger and occa-
sionally have single processes oriented away from the ventricle. C, D, Transgene-labeled (red)
and TUNEL-labeled (green) cells in the SVZ are primarily distinct populations. D, An occasional
transgene/TUNEL-labeled cell can be identified by confocal microscopy in the SVZ (yellow;
arrow). Scale bars: A, 50 m; B, 25 m; width of image in C, 50 m; D, 40 m.
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dying. TUNEL labeling indicates that these
two populations are mostly distinct (Fig.
3C). When imaged confocally (Fig. 3D,E),
only 7.6% of transgene-labeled SVZ cells
were also TUNEL labeled (five double-
labeled cells in five sections each from two
animals; n  66 transgene-labeled cells ex-
amined). Thus, RA-activated precursors
have neither the proliferative nor apoptotic
characteristics of transit-amplifying cells.
RA-activated SVZ cells are astrocytes
To evaluate whether DR5-RARE-
mediated RA signaling is associated with
the other major class of SVZ precursors
(resident slowly dividing astrocytes), we
first examined transgene-labeled cells for
expression of GFAP, a primary diagnostic
marker for this population (Doetsch et al.,
1999b; Morshead et al., 2003; Garcia et al.,
2004). The majority of transgene-labeled
SVZ cells (87%) express GFAP (Fig. 4A–
G), and an additional 9% were ambigu-
ously associated with fibrillary GFAP im-
munoreactivity. Some of these cells have
the fusiform morphology and single pro-
cess associated with SVZ precursors (Gar-
cia et al., 2004) (Fig. 4B,G). A small per-
centage of transgene-labeled cells do not
express GFAP (4%); however, they are ad-
jacent to transgene/GFAP-labeled cells
(Fig. 4B, arrow). Finally, transgene/
GFAP-labeled cells frequently contact
blood vessels (Fig. 4A, inset, G,K). Thus,
the transgene-labeled cells have multiple
characteristics associated with astrocytes
thought to constitute a distinct class of
SVZ precursors.
The EGFR labels a subset of GFAP-
positive cells as well as the majority of
transit-amplifying precursors in the SVZ
(Doetsch et al., 2002). We found that 23%
of transgene-labeled cells express EGFR
(Fig. 4H). Cage-like networks of small
EGFR-expressing cells often surround
large transgene-labeled cells (Fig. 4H, in-
set), and orthogonal confocal projections
indicate that such transgene-labeled cells
do not express EGFR (Fig. 4 I). Most
transgene-labeled cells are completely dis-
tinct from EGFR-expressing cells (Fig. 4 J);
however, they are sometimes intercalated
between EGFR-expressing cells (Fig. 4K).
The smaller population of transgene/EGFR-labeled cells fre-
quently appears as “doublets” (two adjacent cells) in close contact
with the ventricle of the dorsolateral arm of the SVZ (Fig. 4L). To-
gether, the unique quantitative signature of GFAP and EGFR expres-
sion suggests that the RA-activated population constitutes a distinct
subclass of neural precursors (see Fig. 9A).
RA-activated cells are slowly dividing precursors
It has been suggested that resident GFAP-expressing neural precur-
sors in the SVZ divide slowly with a cell cycle time of up to 12 d
(Morshead et al., 1994). Thus, we asked whether RA-activated cells
could incorporate BrdU and remain in the SVZ 1 month after long-
term exposure, a protocol used to identify slowly cycling resident
precursors in other tissues, including the nervous system (Bicken-
bach and Chism, 1998; Otteson et al., 2001). Thirteen percent of
transgene-labeled cells from TG1 mice incorporated BrdU and re-
mained in the SVZ (Fig. 5A–D), and a similar percentage (15%) was
seen in the independent TG2 line. To confirm that this schedule of
BrdU exposure and survival identifies primarily slowly dividing pre-
cursors, we evaluated the frequency of GFAP expression in long-
Figure 4. Most transgene-labeled cells are GFAP-labeled astrocytes. A, Several transgene-labeled cells (red) are seen within a
network of GFAP-labeled cells and processes (green) in the SVZ. The CC indicates orientation of this coronal section. Inset, A
transgene-positive cell that also expresses GFAP (yellow) contacts an apparent blood vessel (asterisk). B, Two transgene/GFAP
double-labeled cells are near or immediately adjacent to a cell labeled for the transgene only (arrow). C, D, Color-separated images
of a transgene/GFAP-labeled cell immediately adjacent to the lateral ventricle. E, Merged image confirms coincidence of GFAP and
the transgene in this cell. F, Orthogonal views (indicated by green and blue lines) of a single 0.3 mm optical section demonstrates
a transgene-positive nucleus surrounded by a GFAP-positive perinuclear ring and intimately associated with GFAP-labeled pro-
cesses. G, A transgene-labeled, fusiform cell with a single long process, also labeled by GFAP, contacts a prominent blood vessel
(asterisk) in the SVZ. H, Low-magnification image shows transgene-labeled (red) and EGFR-labeled cells (green) in a coronal
section of the SVZ. Inset, An individual transgene-labeled cell surrounded by a network of EGFR-labeled cells indicates potential
ambiguity in detecting double labeling. I, Orthogonal views of a single optical section from the inset in H indicate that this
transgene-labeled cell does not express EGFR. J, A single-labeled, large, fusiform transgene-expressing cell is adjacent to two
EGFR-labeled cells (n). K, A transgene-labeled cell and its processes intercalated between EGFR-expressing cells (nuclei labeled n).
In this image, transgene-labeled processes apparently contact a blood vessel (asterisk), whereas those of the EGFR-expressing
cells do not. L, Doublets of transgene-labeled cells that also express EGFR (green) in this unequivocal example of transgene/EGFR-
labeled cells in a single optical section through the SVZ. Scale bars: A, H, 100 m; width of images in B, E–K, 40 m; J, 35 m.
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term versus acutely BrdU-labeled cells. Long-term BrdU-
labeled cells (Fig. 5E) were far less frequent than acutely BrdU-
labeled cells in the SVZ (Fig. 5F ). Nevertheless, in the long-
term labeled SVZ, GFAP/BrdU double-labeled cells were
easily identifiable, whereas in the acutely labeled SVZ, the two
populations were mostly distinct. We confirmed this impres-
sion by quantifying GFAP/BrdU double-labeled cells in con-
focal maximal projections (Fig. 5G). A greater percentage of
BrdU-labeled cells coexpresses GFAP after long-term (65%)
versus acute BrdU exposure (11%) (Fig. 5H ). Thus, in addi-
tion to their molecular expression profile, transgene-labeled
SVZ astrocytes have proliferative kinetics consistent with a
subset of resident, slowly dividing neural precursors (see
Fig. 9A).
RA-activated cells can be identified in subsets of
SVZ-derived neurospheres
If RA-activated SVZ cells are a consistent subset of proliferative
neural precursors, they should be present in neurospheres, which
are thought to represent clonally related SVZ precursors (Weiss
et al., 1996). Primary SVZ-derived neurospheres from transgenic
mice have the same capacity to generate neurons, astrocytes, and
oligodendrocytes as their wild-type counterparts (Fig. 6A–C). In
SVZ-derived neurospheres from TG mice, we identified small to
prominent clusters of transgene-labeled cells using a fluorescent
substrate for -galactosidase, CMFDG (Fig. 6D–F). The percent-
age of primary neurospheres with RA-activated cells was consis-
tent (33%) in cultures generated from two independent lines of
TG mice (n  144 TG1 spheres, SEM  2.8; n  178 TG2 spheres,
SEM  3.8). Fluorescent cells were not seen in non-TG neuro-
spheres incubated with CMFDG (Fig. 6G). In contrast, fluores-
cence was seen throughout primary neurospheres from ROSA26
mice (Fig. 6H), which widely express -galactosidase (Friedrich
and Soriano, 1991; Zambrowicz et al., 1997), indicating that CM-
Figure 5. RA-activated cells in the SVZ are a subset of resident, slowly dividing precursors. A,
Transgene (red) and BrdU-labeled cells (green) in the SVZ (coronal section) 30 d after long-term
exposure (10 mg/ml for 1 week in the drinking water). Inset, High magnification of an optical
section (0.5 m) showing a large transgene-labeled SVZ cell (A, box) with as single process
oriented away from the ventricle that is also labeled by BrdU 30 d after a long-term exposure.
B–D, Examples of transgene-labeled SVZ cells that are also labeled after long-term BrdU expo-
sure (yellow nuclei in cells with red processes and cytoplasm). E, Thirty days after long-term
exposure, several BrdU-labeled cells are scattered throughout the CC but, as shown in A, are rare
in the SVZ. Inset, A long-term BrdU-labeled SVZ cell is clearly labeled for GFAP. F, Distribution of
BrdU- and GFAP-labeled SVZ cells after acute BrdU exposure (2.5 h). The BrdU-labeled cells are
more frequent. Inset, Most acutely labeled BrdU-positive cells do not express GFAP. G, Example
of the 40 confocal maximum projection images used to estimate numbers of BrdU-labeled
cells that express GFAP after acute exposure. H, Quantitative estimate of the proportion of
long-term versus acute BrdU-labeled cells that also express GFAP. Scale bars: A, E, F, 200 m; G,
25 m; width of image in B, 50 m; width of images in C, D, 25 m.
Figure 6. RA-activated cells can be recognized in a subset of SVZ-derived neurospheres.
A–C, SVZ-derived neurospheres from adult DR5-RARE transgenic mice generate neurons (A;
TuJ1, green), astrocytes (B; GFAP, green), and oligodendrocytes (C; O4, green) in the presence of
serum. Nuclei, counterstained with bis-benzamide, are shown in blue. D–H, Live images of
primary neurospheres derived from TG1 (D), TG2 (E, F ), ICR (G), and Rosa-26 (H ) mice after
incubation with CMFDG. I, TG2-derived secondary neurospheres have CMFDG-labeled cells, the
distribution of which is similar to that in primary neurospheres. J, Individual primary neuro-
spheres containing CMFDG transgene-labeled cells consistently produce neurons (TuJ1, green)
and glia (GFAP, red) under differentiation conditions. K–N, Transgene-labeled cells retain ex-
pression of EGFR and GFAP in neurospheres. Confocal projections show EGFR (K ) and GFAP (M )
staining in intact, undifferentiated neurospheres. Transgene-labeled cells (red) express EGFR
(green; L) and GFAP (green; N ) in single 0.5 m optical sections through intact, undifferenti-
ated neurospheres. Scale bars: A–C, 100 m; D–G, I, 100 m; H, 200 m; K, M, 100 m;
width of images in L, N, 25 m.
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FDG can penetrate neurospheres. Fluorescence was not uniform
in ROSA26-derived neurospheres, perhaps reflecting the lack of
expression of this transgene in astrocytes (Anthony et al., 2004).
To determine whether similar populations of RA-activated cells
are retained in clonally propagated neural precursors, we gener-
ated secondary neurospheres in which transgene-labeled cells are
present in a proportion and pattern similar to that seen in pri-
mary neurospheres (Fig. 6 I).
Individual primary neurospheres containing CMFDG-
labeled RA-activated cells consistently produce neurons and glia
(Fig. 6 J); however, transgene-labeled cells were never detected in
these differentiated cultures (data not shown). In undifferenti-
ated neurospheres, transgene-labeled cells retain molecular char-
acteristics seen in RA-activated SVZ cells in vivo. The EGFR is
detected in most neurosphere cells, including those labeled by the
transgene (Fig. 6K,L). GFAP is expressed by a much smaller sub-
set (Fig. 6M), which includes all of the transgene-labeled neuro-
sphere cells (Fig. 6N) (n  26 of 26 transgene-labeled cells).
Thus, in SVZ-derived neurospheres, as in the SVZ, there is a
subset of RA-activated, GFAP-expressing neural precursors.
RA signaling in SVZ-derived neurospheres
RA receptors, synthetic enzymes, and binding proteins are a min-
imal prerequisite for RA signaling in SVZ precursors. There is
widespread expression of RAR, RAR, and RALDH3 in the SVZ
(Fig. 7A–C), consistent with previous observations (Krezel et al.,
1999; Wagner et al., 2002). This expression appears most intense
along the lateral edge of the lateral ventricle, particularly in the
dorsolateral arm. Transcripts for a wide range of RA receptors,
binding proteins, and synthetic enzymes can be detected in the
acutely dissected SVZ (Fig. 7D, top). There is a similar set of
RA-signaling molecules in SVZ-derived neurospheres (Fig. 7D,
bottom); however, RAR4, CRABP1, and RALDH2 are absent.
dlx2, a transcription factor expressed by transit-amplifying pre-
cursors, confirms SVZ and neurosphere identity, and
-galactosidase confirms transgene expression. Thus, overlap-
ping subsets of RA receptors, binding proteins, and synthetic
enzymes are available to support RA signaling in SVZ precursors
in vivo as well as in vitro.
We next determined whether the transgene is specifically acti-
vated by RA in SVZ neural precursors in vitro and thus accurately
reports active RA signaling. We incubated neurospheres with 100 nM
DEAB (Perz-Edwards et al., 2001), an RA synthesis inhibitor, for 4 h
before the addition of CMFDG. Only a single, lightly fluorescent cell
could be identified in 62 DEAB-treated neurospheres (Fig. 7E, panel
1). In contrast, clusters of fluorescent cells could be identified in
untreated neurospheres processed in parallel (Fig. 7E, panel 2) or
those coincubated with all-trans RA and DEAB (Fig. 7E, panel 3). To
determine whether transgene activation in vitro depends on RA syn-
thesis from its presumed in vivo premetabolite retinol, we grew neu-
rospheres in retinol-free B27 medium and assayed CMFDG labeling.
We harvested 83 neurospheres grown without retinol and identified
no fluorescent cells (Fig. 7E, panel 4). Thus, RA signaling in TG-
derived neurospheres depends on RA synthesis, most likely from a
retinol precursor.
We next assessed the capacity of dissociated SVZ cells cultured
in the absence of retinol to form neurospheres. SVZ cells grown
in retinol-free medium generate significantly fewer neurospheres
(32% of control) (i.e., a 68% reduction) (Fig. 7F); however, there
is no significant difference in the size of the remaining neuro-
spheres generated in retinol-free cultures ( p  0.3; Mann–Whit-
ney). If RA was necessary for survival of SVZ precursors that
generate neurospheres, then one would expect to see a significant
increase in dead cells in retinol-free cultures. Thus, we assessed
cell viability in dissociated SVZ cells cultured either in control or
retinol-free media throughout the standard period for neuro-
sphere generation. There was no significant difference in the pro-
portion of live to dead cells in the presence or absence of retinol
(Fig. 7G). Thus, retinol, a primary RA premetabolite, may influ-
ence the ability of a subset of SVZ cells to form neurospheres;
however, general toxicity or enhanced cell death as a result of RA
deprivation is unlikely to explain this change.
Influence of RA signaling on precursor proliferation
The majority of precursors in neurospheres are thought to be
transit-amplifying cells (Doetsch et al., 2002). Thus, if RA acts as
a modulator of slowly dividing precursors, as suggested by our in
vivo data, rather than a mitogen for transit-amplifying cells, one
would not expect RA to enhance cell proliferation in early differ-
entiating neurosphere cultures. To address this issue, we exposed
adult SVZ-derived neurospheres to exogenous RA and analyzed
BrdU incorporation. Acute exposure to either 106 or 107 M RA
for 24 h before differentiation did not significantly alter the mi-
totic index of SVZ precursors (Fig. 7H). In contrast, exposure to
100 nM DEAB results in a significant increase in the proportion of
BrdU-labeled cells ( p  0.006; Mann–Whitney) (Fig. 7H). Thus,
it is unlikely that RA elicits an acute and significant increase in cell
proliferation from the transit-amplifying majority of
neurosphere-derived cells. Instead, RA may modulate prolifera-
tive kinetics in a smaller subset of SVZ-derived precursors.
RA signaling in a subpopulation of SVZ glial cells
during development
RA signaling in the adult forebrain occurs primarily in regions
with embryonic forerunners that are sites of local RA-mediated
induction (LaMantia et al., 1993; Whitesides et al., 1998; Haskell
et al., 2002). We asked whether this regional coincidence is par-
alleled by RA activation in proliferative cells with glial character-
istics in restricted domains of the developing ventral forebrain.
We found RA-activated, RC2-labeled radial glial cells in the ven-
trolateral pallium and dLGE (Fig. 8A–D), embryonic areas that
give rise to the adult SVZ (Merkle et al., 2004). RA receptors
RAR and RAR are expressed throughout the forebrain at this
stage (Fig. 8E,F), and the RA synthetic enzyme RALDH3 is concen-
trated in the embryonic SVZ (Fig. 8G). RA-activated cells (Fig. 8H)
define a more discrete zone at the junction of the ventral pallium/
dLGE within the Pax6 domain of the neocortical rudiment (Fig. 8I)
as well as the LGE-restricted Gsh2 domain (Fig. 8J). The zone of RA
activation is most coincident with the ER81 domain associated with
the dLGE region thought to generate OB granule cells (Fig. 8K)
(Wichterle et al., 1999; Stenman et al., 2003).
We next evaluated the proliferative capacity of the RA-
activated radial glial cells in vivo and in vitro. A substantial pop-
ulation of RA-activated radial cells is mitotically labeled after
acute exposure to BrdU (Fig. 8L). The presence of RA-activated
cells in primary neurospheres cultured from dissociated E14.5
ventral pallium/dLGE is consistent with their apparent precursor
identity (Fig. 8M). Moreover, RA-activated cells are not seen in
differentiated neurons in glia in cultures from E14.5 neuro-
spheres (data not shown). RA-activated cells persist in the ventral
pallium/dLGE through at least P2 (Fig. 8N), when radial glia
transform into mature SVZ astrocytes (Tramontin et al., 2003).
At P2, these transgene-labeled cells coexpress the radial glial
marker glial glutamate transporter (GLAST) and GFAP (Fig. 8O–
Q). Thus, subsets of RA-activated precursors with evolving glial
characteristics are found consistently at similar sites (the SVZ and
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Figure 7. RA signaling in the SVZ and in SVZ-derived precursors. A, Left, RAR mRNA can be detected in the ventricular region in a low-magnification image of the lateral ventricle. Right,
RAR-expressing cells are concentrated in the SVZ and are detected at much lower intensity in the striatum (ST). B, The distribution of RAR parallels that of RAR. C, RALDH3, an RA synthetic
enzyme, is seen around the lateral ventricle, concentrated in the SVZ, as well as in the choroid plexus (inset). D, RA-signaling molecules are expressed in acutely microdissected adult TG2 SVZ (top)
and SVZ-derived primary neurospheres (bottom). RAR4, CRABP1, and RALDH2, which are expressed in the SVZ, are not detected in neurospheres. E, Transgene activation in SVZ-derived
neurospheres depends on RA, synthesized from retinol. Top, Transgene-expressing cells are virtually undetectable in TG neurospheres incubated for 4 h with DEAB, an RA synthesis inhibitor. Middle,
Top, Control TG neurospheres processed in parallel contain transgene-expressing cells. Middle, Bottom, Transgene expression is restored in TG neurospheres coincubated with DEAB and RA 4 h before
CMFDG incubation. Bottom, Transgene-expressing cells cannot be detected in TG neurospheres grown in the absence of retinol, the requisite metabolic precursor of RA. F, The RA precursor retinol
is necessary to generate normal numbers of SVZ-derived neurospheres in vitro. The histogram shows a comparison of numbers of primary neurospheres generated in retinol-free media compared
with control. The error bar indicates SEM (n  9 sets of control and retinol-free cultures). G, Absence of retinol does not induce cell death in SVZ cells. Left, The histogram indicates no difference in
the proportions of live to dead SVZ cells cultured in control or retinol-free medium over the 9 d period of neurosphere generation. Right, Examples of live cells (green) and presumed dead cells (red)
in the live/dead assay used to quantify cell viability during neurosphere generation. H, RA modulates SVZ precursor proliferation in vitro. Left, The histogram illustrates the proportion of BrdU-labeled
cells in adult SVZ neurospheres acutely exposed to either 10 6 or 10 7 M RA or 100 nM DEAB. Right, Examples of BrdU labeling in control (top) or DEAB-treated (bottom) differentiating cultures from
neurospheres. Scale bars: B, Left, 0.5 mm; Right, 50 m.
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its anatomical antecedent, the ventrolateral pallium/dLGE) in the
adult and embryonic forebrain (Fig. 9B).
Discussion
We have shown for the first time that endogenous RA signaling
via an identified transcriptional pathway distinguishes forebrain
neural precursors. In the adult SVZ, RA activates a subset of
GFAP-expressing, slowly dividing astrocytes. The cellular prop-
erties and RA sensitivity of adult SVZ-derived precursors in vitro
reinforce the impression that retinoids act on a distinct glial pop-
ulation rather than transit-amplifying cells or their immediate
neuronal progeny. In embryonic regions that prefigure the SVZ,
there are also RA-responsive, mitotically active radial glial cells.
Thus, adult as well as embryonic forebrain neural precursors may
be added to the list of diverse precursor cells that include RA in
their signaling repertoire. This RA signaling in distinct subsets of
spatially coincident forebrain glia may establish or maintain neu-
rogenic or proliferative properties of OB precursors throughout
prenatal and postnatal life.
Defining RA signaling in the SVZ
We used a previously characterized RA reporter transgene (Bal-
kan et al., 1992; Colbert et al., 1993, 1995; LaMantia et al., 1993;
Haskell et al., 2002) and several independent markers to identify
SVZ cells that respond to endogenous RA. This approach inte-
grates the influence of multiple RA-signaling molecules that es-
tablish a distinct transcriptional state (via the DR5-RARE) as
opposed to relying on the singular expression of any one RA-
related factor to infer retinoid-mediated transcriptional activa-
tion. Thus, one can identify subsets of RA-activated cells in re-
gions like the SVZ or developing forebrain, where RA signaling
molecules are widely available. Several observations validate the
specificity of this approach. RA-activated neural precursors have
identical characteristics in two independent transgenic lines. Fur-
thermore, transgene expression in SVZ-derived precursors in
vitro is sensitive to the RA synthesis inhibitor DEAB and depends
on the RA premetabolite retinol. Thus, this RA-responsive trans-
gene, in the context of other markers, provides a specific, physi-
ologically verifiable approach to selectively identify forebrain
precursors that include a distinct RA-mediated transcriptional
response among their cellular characteristics.
Multiple roles for RA signaling
We identified RA-activated granule cells in the adult OB; how-
ever, they are not new neurons. Instead, they are generated early,
do not die in large numbers, and persist in the adult. It seems
unlikely that these cells and the RA-activated SVZ precursors that
we characterized are directly linearly related. Instead, there may
be independent roles for RA at distinct olfactory sites: one asso-
ciated with stable granule cells generated during early postnatal
life and another with slowly proliferating SVZ glia. Altered RA
signaling in vitro modulates a variety of cellular mechanisms in
tissues from the prenatal or early postnatal olfactory pathway
(Whitesides et al., 1998; Wang et al., 2005; Yee and Rawson,
2005), The specific activation by RA of the two cell classes iden-
tified here amplifies the conclusion that retinoids, via a range of
transcriptional pathways including the DR5-RARE, may help to
define cellular diversity in the olfactory pathway.
We did not detect RA-activated cells in the hippocampus de-
spite ongoing neurogenesis in the subgranular zone, which is
often compared with that in the SVZ. Recent reports suggest that
exogenous RA influences hippocampal granule cell precursor
proliferation (Crandall et al., 2004), and that changes in hip-
pocampal plasticity accompany altered retinoid signaling
(Chiang et al., 1998; Misner et al., 2001). RA signaling in the SVZ
may have a distinct function from that in the hippocampus. SVZ
precursors generate olfactory inhibitory interneurons, whereas
their hippocampal counterparts generate primarily projection
neurons (Seaberg and van der Kooy, 2002). In the adult, as in the
Figure 8. RA-activated, proliferative radial glia in embryonic brain regions that give rise to
the SVZ as well as OB granule cells. A, Transgene-labeled, radial cells are seen in the dLGE as well
as the lateral portion of the neocortical rudiment in the E14.5 forebrain. B, Transgene-labeled
cells constitute a subset of RC2-positive radial cells in the LGE. C, D, Colocalization of RC2 and the
transgene is seen in individual cells in single optical sections (0.5 m). E–G, RAR (E) and
RAR (F ) are ubiquitously expressed in pallial as well as LGE cells, whereas RALDH3 (G) is
limited to the embryonic SVZ. The insets show that in labeled regions, every recognizable cell
expressed the relevant mRNA. H–K, E14.5 RA-activated radial cells (H ) are located at the junc-
tion of the ventral pallium/dLGE that spans transcriptional domains defined by Pax6 (I ) and
Gsh2 (J ). Transgene-labeled cells are most closely spatially associated with the expression
domain of ER81 (K ), which has been associated with the region that gives rise to OB granule
cells. L, At E14.5, some transgene-labeled cells (red) are also BrdU labeled 1 h after a single
injection of BrdU. Inset, A higher-power image of the section in K showing BrdU labeling (green)
of individual RA-activated cells (red). M, Transgene-labeled cells are present in a subset of E14.5
neurospheres. M–P, Triple labeling for -gal (N ), GLAST (O), and GFAP (P) at P2 (Q; merged
image). Scale bars: B, 50 m; E–G, 250 m; H–J, 100 m; K, 25 m; L, 100 m; M–P, 30
m; width of image in C, 15 m; D, 20 m.
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embryo, transgene-labeled cells are restricted to regions associ-
ated with genesis of GABAergic interneurons, including the ru-
dimentary OB and SVZ as well as lamina 2 of the spinal cord
dorsal horn (Haskell et al., 2002). Our results reinforce the idea
that RA signaling distinguishes “intermediate” telencephalic pre-
cursors (Marklund et al., 2004) associated with giving rise to
olfactory, amygdalar, or striatal neurons. Thus, DR5-RARE-
mediated RA signaling may be particularly important for genesis
or maintenance of inhibitory interneurons in the OB and other
selected sites, especially those that rely on RA signaling during
early development.
DR5-RARE/RA-activated cells are slowly
dividing, resident SVZ precursors
A majority of RA-activated SVZ cells express
GFAP, the primary marker associated with
slowly dividing neural precursors, which
may include a population of adult neural
stem cells (Fig. 9A) (Doetsch et al., 1999b;
Palmer et al., 2000; Morshead et al., 2003;
Shen et al., 2004). This quantitative confocal
analysis corrects our initial impression,
based on epifluorescence microscopy, that
RA-activated cells were not labeled by GFAP
(Haskell et al., 2002). The mitotic profile of
RA-activated cells, recognized by long-term
BrdU exposure, associates them most se-
curely with resident, slowly dividing neural
precursors. Nevertheless, the lack of specific
markers beyond GFAP, nestin, Sox1, and
Sox2 (all of which are expressed in RA-
activated cells) makes it impossible to assign
an identity beyond neural precursor to the
RA-activated cells described here. A subset of
RA-activated cells (23%) also expresses the
EGFR, which has been associated with SVZ
precursor proliferation in vitro and in vivo
(Tropepe et al., 1997). At least some RA-
activated cells, including 4% that do not ex-
press GFAP, may respond to this mitogen,
perhaps during a transition from quiescent
to mitotically active, fate-restricted precur-
sors (Doetsch et al., 2002). Neither our in
vivo nor our in vitro observations can resolve
whether the RA-activated cells characterized
here have additional stem cell properties;
nevertheless, our data establishes that RA
signaling distinguishes a subset of resident
slowly dividing neural precursors in the
adult SVZ.
Role of RA signaling in SVZ precursors
We used neurospheres, which recapitulate
several features of the SVZ, to further eval-
uate RA signaling in forebrain-derived
precursors. RA signaling characterizes a
small but consistent subset of GFAP-
positive precursors in vitro as in vivo, and
loss of transgene activation after inhibiting
RA synthesis indicates that these cells are
actively responding to RA. We cannot
comment on the relationship between
neurospheres containing RA-activated
cells and potential RA-activated founders
from the SVZ. Nevertheless, it is clear that RA signaling estab-
lishes cellular diversity among precursors propagated in vitro,
perhaps reflecting similar diversity in the SVZ in vivo. The ab-
sence of transgene labeling in neurons or glia differentiated from
neurospheres reinforces our in vivo observation that DR5-RARE-
mediated RA activation is not associated with newly generated
neurons or differentiated glia.
The acute effects of pharmacological loss and gain of function
indicate that RA may stabilize or modestly diminish, rather than
enhance, neurosphere precursor proliferation. These in vitro
data, in accord with our in vivo data, indicate that RA does not act
Figure 9. A, DR5-RARE/RA-activated astrocytes are a subset of resident, slowly dividing SVZ neural precursors. Our observa-
tions are summarized graphically in the first row; those in the subsequent rows are a synthesis of our observations and those of
several other investigators defining distinct SVZ cell classes. Solid yellow indicates that a percentage of colocalization has been
quantified. Graded yellow indicates ambiguity as a result of no data on colocalization of relevant markers. Hatching represents
expression presumed to occur throughout the population indicated; however, the coincidence of these and other labels, including
the transgene, has not been quantified. Hatching density is proportional to levels of expression. B, RA-activated cells with radial
glial or astrocytic properties are found at a consistent site in the developing and adult forebrain. Initially (E9.5–E10.5), these cells
occupy a subdomain of the ventrolateral prosencephalon overlapping both the Pax6 and Gsh2 transcriptional domains. Subse-
quently (E14.5), proliferative RA-activated radial glial cells are seen in a similar region, now identified as the ventral pallium/dLGE,
in register with the Er81 transcriptional domain. At P2, RA-activated glial cells make a transition from embryonic radial cells to
mature astrocytes in the incipient SVZ, and they become less frequent. In the adult, a small population of RA activated, slowly
dividing, GFAP-expressing precursors remain in the SVZ, thus maintaining the continuity of RA-activated cells in this region
throughout life.
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as a proliferative signal for transit-amplifying cells via DR5-
RARE-dependent transcriptional pathways (Fig. 9A). Endoge-
nous, locally available RA may regulate neural precursors with
broader potential or sustained mitotic capacity without acutely
eliciting cell death or proliferation (Morshead et al., 2002), per-
haps in 33% of neurospheres that include transgene-labeled cells
rather than 70% thought to derive from transit-amplifying pre-
cursors (Doetsch et al., 2002). RA signaling may establish a com-
plex transcriptional state in combination with several other mo-
lecular determinants (beyond a specific group of retinoid
receptors or cofactors, including the subset examined here) to
influence precursor identity or differentiation (Cheng et al.,
2005). Resolution of this question will require better tools for
sorting and identifying single RA-activated cells from the SVZ for
clonal analysis in response to a variety of RA-signaling
conditions.
Continuity of RA signaling in the developing and
adult forebrain
RA signaling distinguishes precursors with overlapping cellular
characteristics in the ventricular region of the ventrolateral fore-
brain throughout life. Such cells may be specified as early as E9.5,
when RA from the frontonasal mesenchyme activates RA signal-
ing in adjacent neuroepithelial cells located in the ventrolateral
forebrain (Fig. 9B) (LaMantia et al., 1993, 2000; Anchan et al.,
1997). It is not clear whether these cells and, subsequently, RA-
activated radial glial cells are linearly related to adult SVZ astro-
cytes (Alvarez-Buylla et al., 2001; Gotz, 2003; Anthony et al.,
2004). Changes in early transcription factor expression that co-
incides with the RA-activated region of the ventral forebrain,
including Pax6, Gsh2, and ER81, as well as distinct proliferative
kinetics in a developing versus regenerating neuroepithelium,
may set different contexts for DR5-RARE-mediated RA signal-
ing. Nevertheless, the spatial coincidence as well as shared cellular
properties of RA-activated cells in the ventral prosencephalon,
ventral pallium/dLGE, and adult SVZ suggests that related sub-
populations of forebrain precursors may be further specified by
endogenous, local RA signaling throughout life, especially in
forebrain regions associated with the initial genesis or subsequent
replacement of olfactory bulb interneurons.
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